| NCT03365648 |
Efficacy and Safety of Lertal® as an add-on to Standard Therapy for Allergic Rhinoconjunctivitis in Pediatrics |
https://ClinicalTrials.gov/show/NCT03365648 |
Completed |
NTC srl |
2018-07-04 |
| NCT03379311 |
A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT03379311 |
Completed |
Allakos, Inc. |
2019-08-08 |
| NCT03375775 |
Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children |
https://ClinicalTrials.gov/show/NCT03375775 |
Active, not recruiting |
Karolinska Institutet |
2022-01-31 |
| NCT03368339 |
Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT03368339 |
Completed |
Realm Therapeutics, Inc. |
2018-01-21 |
| NCT03320434 |
Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT03320434 |
Completed |
ORA, Inc. |
2018-02-16 |
| NCT03231969 |
A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model |
https://ClinicalTrials.gov/show/NCT03231969 |
Completed |
Faes Farma, S.A. |
2017-10-11 |
| NCT03186755 |
Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT03186755 |
Recruiting |
St. Justine’s Hospital |
2020-12-31 |
| NCT03012165 |
A Study of ADX-102 in Subjects With Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT03012165 |
Completed |
Aldeyra Therapeutics, Inc. |
2017-05-31 |
| NCT03004924 |
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo |
https://ClinicalTrials.gov/show/NCT03004924 |
Completed |
Shire |
2018-10-01 |
| NCT02988882 |
OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT02988882 |
Completed |
Ocular Therapeutix, Inc. |
2016-04-30 |
| NCT02980523 |
Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin) |
https://ClinicalTrials.gov/show/NCT02980523 |
Completed |
Laboratorios Sophia S.A de C.V. |
2016-06-30 |
| NCT02978183 |
Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT02978183 |
Completed |
Noveome Biotherapeutics, formerly Stemnion |
2017-02-28 |
| NCT02881879 |
Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust Mites |
https://ClinicalTrials.gov/show/NCT02881879 |
Completed |
Roxall Medicina España S.A |
2017-09-30 |
| NCT02661854 |
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy |
https://ClinicalTrials.gov/show/NCT02661854 |
Active, not recruiting |
Inmunotek S.L. |
2020-07-31 |
| NCT02654223 |
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy |
https://ClinicalTrials.gov/show/NCT02654223 |
Recruiting |
Inmunotek S.L. |
2020-12-31 |
| NCT02506998 |
Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts |
https://ClinicalTrials.gov/show/NCT02506998 |
Completed |
National Polytechnic Institute, Mexico |
2015-01-31 |
| NCT02503956 |
Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients |
https://ClinicalTrials.gov/show/NCT02503956 |
Completed |
Rabin Medical Center |
2016-07-22 |
| NCT02492321 |
A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT02492321 |
Completed |
Eleven Biotherapeutics |
2015-11-30 |
| NCT02477917 |
A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica |
https://ClinicalTrials.gov/show/NCT02477917 |
Completed |
Roxall Medicina España S.A |
2016-03-31 |
| NCT02472223 |
Reducing Adenoviral Patient Infected Days |
https://ClinicalTrials.gov/show/NCT02472223 |
Recruiting |
Washington University School of Medicine |
2020-01-31 |
| NCT02445326 |
OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT02445326 |
Completed |
Ocular Therapeutix, Inc. |
2015-08-31 |
| NCT02432807 |
Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis |
https://ClinicalTrials.gov/show/NCT02432807 |
Completed |
Kurobe LLC |
2018-05-31 |
| NCT02340130 |
Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma |
https://ClinicalTrials.gov/show/NCT02340130 |
Completed |
Laboratorios Leti, S.L. |
2018-05-31 |
| NCT02322216 |
Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects |
https://ClinicalTrials.gov/show/NCT02322216 |
Completed |
Alcon Research |
2015-10-31 |
| NCT02308501 |
A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy |
https://ClinicalTrials.gov/show/NCT02308501 |
Completed |
ORA, Inc. |
2015-02-28 |
| NCT02271009 |
Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EEC |
https://ClinicalTrials.gov/show/NCT02271009 |
Completed |
Anergis |
2015-05-31 |
| NCT02251613 |
Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan |
https://ClinicalTrials.gov/show/NCT02251613 |
Completed |
Alcon Research |
2014-01-31 |
| NCT02231307 |
SUBLIVAC FIX Birch Phase III Short-term Efficacy |
https://ClinicalTrials.gov/show/NCT02231307 |
Completed |
HAL Allergy |
2015-07-31 |
| NCT02161146 |
AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT02161146 |
Completed |
Allergan |
2014-12-20 |
| NCT02150343 |
Phase II HDM-SPIRE Safety and Efficacy Study |
https://ClinicalTrials.gov/show/NCT02150343 |
Completed |
Circassia Limited |
2017-04-13 |
| NCT02148744 |
Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis |
https://ClinicalTrials.gov/show/NCT02148744 |
Completed |
Xencor, Inc. |
2015-09-21 |
| NCT02132169 |
A Multi-Center Study Evaluating the Safety of AC-170 0.24% |
https://ClinicalTrials.gov/show/NCT02132169 |
Completed |
Aciex Therapeutics, Inc. |
2014-10-31 |
| NCT02082899 |
A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1) |
https://ClinicalTrials.gov/show/NCT02082899 |
Completed |
Eleven Biotherapeutics |
2014-06-30 |
| NCT02082262 |
AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT02082262 |
Completed |
Allergan |
2014-07-31 |
| NCT02079649 |
Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT02079649 |
Completed |
Alcon Research |
2014-07-31 |
| NCT02062905 |
OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT02062905 |
Completed |
Ocular Therapeutix, Inc. |
2014-08-31 |
| NCT01294969 |
Patient Perception Study for AL-4943A |
https://ClinicalTrials.gov/show/NCT01294969 |
Completed |
Alcon Research |
2011-10-31 |
| NCT01289431 |
Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01289431 |
Completed |
Bausch & Lomb Incorporated |
2011-04-30 |
| NCT01282138 |
Assessment of Alcon’s Ocular Image Quantification System |
https://ClinicalTrials.gov/show/NCT01282138 |
Completed |
Alcon Research |
2011-03-31 |
| NCT01275105 |
A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC) |
https://ClinicalTrials.gov/show/NCT01275105 |
Completed |
Eye Therapies, LLC |
2011-03-31 |
| NCT01272089 |
A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01272089 |
Completed |
Alcon Research |
2011-12-31 |
| NCT01977443 |
Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC) |
https://ClinicalTrials.gov/show/NCT01977443 |
Completed |
Adenovir Pharma AB |
2016-09-30 |
| NCT01949441 |
ToleroMune House Dust Mite (HDM) Tolerability Study |
https://ClinicalTrials.gov/show/NCT01949441 |
Completed |
Circassia Limited |
2014-05-31 |
| NCT01921257 |
Paediatric Safety Study in Cat-PAD |
https://ClinicalTrials.gov/show/NCT01921257 |
Completed |
Circassia Limited |
2015-12-31 |
| NCT01902992 |
Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch |
https://ClinicalTrials.gov/show/NCT01902992 |
Completed |
Novartis |
2012-07-31 |
| NCT01881113 |
A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle |
https://ClinicalTrials.gov/show/NCT01881113 |
Completed |
Aciex Therapeutics, Inc. |
2013-10-31 |
| NCT01877694 |
Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01877694 |
Completed |
NovaBay Pharmaceuticals, Inc. |
2014-12-31 |
| NCT01852825 |
MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009) |
https://ClinicalTrials.gov/show/NCT01852825 |
Completed |
Merck Sharp & Dohme Corp. |
2015-07-20 |
| NCT01799863 |
Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01799863 |
Completed |
Fundação Altino Ventura |
2013-03-31 |
| NCT01754766 |
AGN-229666 for the Treatment of Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01754766 |
Completed |
Allergan |
2013-01-31 |
| NCT01743027 |
Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01743027 |
Completed |
Alcon Research |
2013-07-31 |
| NCT01740284 |
A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine |
https://ClinicalTrials.gov/show/NCT01740284 |
Completed |
ALK-Abelló A/S |
2009-01-31 |
| NCT01732757 |
A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01732757 |
Completed |
Allergan |
2012-12-31 |
| NCT01731249 |
Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis |
https://ClinicalTrials.gov/show/NCT01731249 |
Completed |
Stallergenes Greer |
2012-07-31 |
| NCT01730872 |
Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model |
https://ClinicalTrials.gov/show/NCT01730872 |
Completed |
ORA, Inc. |
2012-12-31 |
| NCT01698814 |
A Six-Week Safety Study of an Investigational Ophthalmic Solution |
https://ClinicalTrials.gov/show/NCT01698814 |
Completed |
Alcon Research |
2013-01-31 |
| NCT01697969 |
Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients |
https://ClinicalTrials.gov/show/NCT01697969 |
Completed |
Alcon Research |
2013-07-31 |
| NCT01694836 |
Depigoid Birch 5000 Longterm Study in Adults and Adolescents |
https://ClinicalTrials.gov/show/NCT01694836 |
Completed |
Leti Pharma GmbH |
2018-07-30 |
| NCT01685242 |
A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle |
https://ClinicalTrials.gov/show/NCT01685242 |
Completed |
Aciex Therapeutics, Inc. |
2012-11-30 |
| NCT01682070 |
SUBLIVAC FIX Phleum Pratense DT/DRF |
https://ClinicalTrials.gov/show/NCT01682070 |
Completed |
HAL Allergy |
2013-05-31 |
| NCT01639846 |
Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01639846 |
Completed |
C.T. Development America, Inc. |
2012-08-31 |
| NCT01639768 |
SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding |
https://ClinicalTrials.gov/show/NCT01639768 |
Completed |
HAL Allergy |
2013-03-31 |
| NCT01620762 |
Phase III Cat-PAD Study |
https://ClinicalTrials.gov/show/NCT01620762 |
Completed |
Circassia Limited |
2016-06-30 |
| NCT01573910 |
An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients |
https://ClinicalTrials.gov/show/NCT01573910 |
Completed |
Alcon Research |
2014-04-30 |
| NCT01569191 |
Non-Pharmaceutical Treatment of Seasonal Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01569191 |
Completed |
Aston University |
2012-11-30 |
| NCT01567306 |
Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense |
https://ClinicalTrials.gov/show/NCT01567306 |
Completed |
Roxall Medicina España S.A |
2013-04-30 |
| NCT01564017 |
Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) Extract |
https://ClinicalTrials.gov/show/NCT01564017 |
Completed |
Roxall Medicina España S.A |
2013-05-31 |
| NCT01561521 |
An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01561521 |
Completed |
Akorn, Inc. |
2012-04-30 |
| NCT01554956 |
Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients |
https://ClinicalTrials.gov/show/NCT01554956 |
Active, not recruiting |
Kedrion S.p.A. |
2014-04-30 |
| NCT01551056 |
A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC) |
https://ClinicalTrials.gov/show/NCT01551056 |
Completed |
Aciex Therapeutics, Inc. |
2012-06-30 |
| NCT01534195 |
Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model |
https://ClinicalTrials.gov/show/NCT01534195 |
Completed |
ORA, Inc. |
2012-02-29 |
| NCT01533480 |
A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01533480 |
Completed |
Lifelong Vision Foundation |
2014-12-31 |
| NCT01532336 |
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01532336 |
Completed |
NovaBay Pharmaceuticals, Inc. |
2014-05-31 |
| NCT01490411 |
Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis |
https://ClinicalTrials.gov/show/NCT01490411 |
Completed |
Allergopharma GmbH & Co. KG |
2011-04-30 |
| NCT01489020 |
Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT) |
https://ClinicalTrials.gov/show/NCT01489020 |
Completed |
Roxall Medicina España S.A |
2011-07-31 |
| NCT01481519 |
A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01481519 |
Completed |
University of Campinas, Brazil |
2012-12-31 |
| NCT01479374 |
Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model |
https://ClinicalTrials.gov/show/NCT01479374 |
Completed |
Alcon Research |
2012-03-31 |
| NCT01471184 |
The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo |
https://ClinicalTrials.gov/show/NCT01471184 |
Completed |
Bitop AG |
2010-03-31 |
| NCT01470664 |
FST-100 in the Treatment of Acute Adenoviral Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01470664 |
Completed |
Shire |
2014-05-31 |
| NCT01470118 |
A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01470118 |
Completed |
Allergan |
2011-12-31 |
| NCT01461954 |
FST-100 in the Treatment of Acute Viral Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01461954 |
Completed |
Shire |
2014-02-28 |
| NCT01443442 |
Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01443442 |
Completed |
Southern California College of Optometry |
2012-09-30 |
| NCT01439815 |
An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo |
https://ClinicalTrials.gov/show/NCT01439815 |
Completed |
ORA, Inc. |
2011-10-31 |
| NCT01438463 |
PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis |
https://ClinicalTrials.gov/show/NCT01438463 |
Completed |
HAL Allergy |
2013-05-31 |
| NCT01437982 |
A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5% |
https://ClinicalTrials.gov/show/NCT01437982 |
Completed |
Bausch & Lomb Incorporated |
2015-10-19 |
| NCT01435460 |
Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC) |
https://ClinicalTrials.gov/show/NCT01435460 |
Completed |
Bausch & Lomb Incorporated |
2011-04-30 |
| NCT01433510 |
Tolerability of Grazax in Patients With Hayfever in Real Life Settings |
https://ClinicalTrials.gov/show/NCT01433510 |
Completed |
ALK-Abelló A/S |
2010-10-31 |
| NCT01425788 |
Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense |
https://ClinicalTrials.gov/show/NCT01425788 |
Completed |
ALK-Abelló A/S |
2011-11-30 |
| NCT01385371 |
A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067) |
https://ClinicalTrials.gov/show/NCT01385371 |
Completed |
ALK-Abelló A/S |
2012-08-31 |
| NCT01363713 |
A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01363713 |
Completed |
Santen Pharmaceutical Co., Ltd. |
2012-09-30 |
| NCT01363700 |
Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01363700 |
Completed |
Santen Pharmaceutical Co., Ltd. |
2012-06-30 |
| NCT01353755 |
2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma |
https://ClinicalTrials.gov/show/NCT01353755 |
Completed |
Allergopharma GmbH & Co. KG |
2012-08-31 |
| NCT01349452 |
Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis |
https://ClinicalTrials.gov/show/NCT01349452 |
Completed |
Federal University of São Paulo |
2009-12-31 |
| NCT01346371 |
The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer |
https://ClinicalTrials.gov/show/NCT01346371 |
Completed |
Minnesota Eye Consultants, P.A. |
2012-08-31 |
| NCT01344083 |
Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01344083 |
Completed |
Laboratoires Thea |
2012-02-29 |
| NCT01342601 |
Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents |
https://ClinicalTrials.gov/show/NCT01342601 |
Completed |
Bitop AG |
2011-09-30 |
| NCT01332188 |
Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model |
https://ClinicalTrials.gov/show/NCT01332188 |
Completed |
Aciex Therapeutics, Inc. |
2011-06-30 |
| NCT01326858 |
Safety and Comfort of AL-4943A Ophthalmic Solution |
https://ClinicalTrials.gov/show/NCT01326858 |
Completed |
Alcon Research |
2011-06-30 |
| NCT01320553 |
Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01320553 |
Completed |
Sun Pharma Advanced Research Company Limited |
2011-08-31 |
| NCT03616899 |
Safety and Efficacy of KPI-121 in Subjects With DED |
https://ClinicalTrials.gov/show/NCT03616899 |
Completed |
Kala Pharmaceuticals, Inc. |
2020-02-05 |
| NCT04275232 |
Allogenic Plasma Aliquots in the Treatment of Ligneous Conjunctivitis |
https://ClinicalTrials.gov/show/NCT04275232 |
Enrolling by invitation |
Memorial University of Newfoundland |
2022-05-31 |
| NCT04207736 |
The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis. |
https://ClinicalTrials.gov/show/NCT04207736 |
Recruiting |
Aldeyra Therapeutics, Inc. |
2020-09-30 |
| NCT04176185 |
A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber |
https://ClinicalTrials.gov/show/NCT04176185 |
Recruiting |
ALK-Abelló A/S |
2020-10-15 |
| NCT04050865 |
A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT04050865 |
Active, not recruiting |
Ocular Therapeutix, Inc. |
2020-02-29 |
| NCT03987178 |
Microbiologic Alterations of the Conjunctiva of Hot Tub-soaking Ophthalmologists |
https://ClinicalTrials.gov/show/NCT03987178 |
Recruiting |
University of California, San Francisco |
2020-05-08 |
| NCT03861728 |
Viral Conjunctivitis Treatment Study |
https://ClinicalTrials.gov/show/NCT03861728 |
Recruiting |
University of Miami |
2021-06-01 |
| NCT03856645 |
OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis |
https://ClinicalTrials.gov/show/NCT03856645 |
Recruiting |
Okogen |
2020-12-31 |
| NCT03839069 |
Minor Salivary Gland Transplantation for Cicatrizing Conjunctivitis |
https://ClinicalTrials.gov/show/NCT03839069 |
Recruiting |
National Taiwan University Hospital |
2020-12-31 |
| NCT03758456 |
HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human |
https://ClinicalTrials.gov/show/NCT03758456 |
Completed |
HAL Allergy |
2019-05-17 |
| NCT03755557 |
Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray |
https://ClinicalTrials.gov/show/NCT03755557 |
Completed |
Marinomed Biotech AG |
2019-04-05 |
| NCT03749317 |
Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis |
https://ClinicalTrials.gov/show/NCT03749317 |
Recruiting |
IVIEW Therapeutics Inc. |
2020-11-30 |
| NCT03709121 |
A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber |
https://ClinicalTrials.gov/show/NCT03709121 |
Completed |
Aldeyra Therapeutics, Inc. |
2019-03-20 |
| NCT03696342 |
Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%. |
https://ClinicalTrials.gov/show/NCT03696342 |
Recruiting |
Laboratorios Sophia S.A de C.V. |
2020-01-31 |
| NCT03682965 |
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study |
https://ClinicalTrials.gov/show/NCT03682965 |
Completed |
Texan Allergy & Sinus Center |
2019-03-06 |
| NCT03660878 |
A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT03660878 |
Completed |
Aldeyra Therapeutics, Inc. |
2019-11-19 |
| NCT03519516 |
Safety and Tolerability of the PRO-174 Versus SophixÃn Ofteno®, on the Ocular Surface of Healthy Subjects |
https://ClinicalTrials.gov/show/NCT03519516 |
Completed |
Laboratorios Sophia S.A de C.V. |
2018-05-25 |
| NCT03494504 |
ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT03494504 |
Completed |
Aldeyra Therapeutics, Inc. |
2018-11-05 |
| NCT03489941 |
A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle |
https://ClinicalTrials.gov/show/NCT03489941 |
Completed |
EyeMax, LLC |
2018-04-29 |
| NCT03479307 |
A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model |
https://ClinicalTrials.gov/show/NCT03479307 |
Completed |
Faes Farma, S.A. |
2018-08-09 |
| NCT01258309 |
Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01258309 |
Completed |
Allergan |
2011-01-31 |
| NCT01203540 |
Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients |
https://ClinicalTrials.gov/show/NCT01203540 |
Completed |
Laboratoires Thea |
NA |
| NCT01179412 |
Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine |
https://ClinicalTrials.gov/show/NCT01179412 |
Completed |
Mahidol University |
2009-12-31 |
| NCT01178762 |
The Effect of Oral Azithromycin in the Treatment of Chlamydial Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01178762 |
Completed |
National Taiwan University Hospital |
2007-11-30 |
| NCT01175590 |
Safety of Besivanceâ„¢ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle |
https://ClinicalTrials.gov/show/NCT01175590 |
Completed |
Bausch & Lomb Incorporated |
2011-12-31 |
| NCT01174823 |
Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis Patients |
https://ClinicalTrials.gov/show/NCT01174823 |
Completed |
Bausch & Lomb Incorporated |
2010-10-31 |
| NCT01159769 |
Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01159769 |
Completed |
Alcon Research |
2010-08-31 |
| NCT01159015 |
Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01159015 |
Completed |
Bausch & Lomb Incorporated |
2010-09-30 |
| NCT01155999 |
Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children. |
https://ClinicalTrials.gov/show/NCT01155999 |
Completed |
Laboratoires Thea |
2011-02-28 |
| NCT01144429 |
Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma |
https://ClinicalTrials.gov/show/NCT01144429 |
Completed |
Leti Pharma GmbH |
2011-02-28 |
| NCT01134328 |
Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CACâ„¢ Model |
https://ClinicalTrials.gov/show/NCT01134328 |
Completed |
Aciex Therapeutics, Inc. |
2010-07-31 |
| NCT01120132 |
Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01120132 |
Completed |
Fovea Pharmaceuticals SA |
2010-08-31 |
| NCT01119287 |
Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01119287 |
Completed |
Alcon Research |
2010-09-30 |
| NCT01111279 |
Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis |
https://ClinicalTrials.gov/show/NCT01111279 |
Completed |
BioTech Tools S.A. |
2010-09-30 |
| NCT01109485 |
Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients |
https://ClinicalTrials.gov/show/NCT01109485 |
Completed |
Alcon Research |
2011-07-31 |
| NCT01107405 |
Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge |
https://ClinicalTrials.gov/show/NCT01107405 |
Completed |
Bausch & Lomb Incorporated |
2010-05-31 |
| NCT01081574 |
Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU) |
https://ClinicalTrials.gov/show/NCT01081574 |
Completed |
Faes Farma, S.A. |
2012-06-30 |
| NCT01037179 |
An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT01037179 |
Completed |
Alcon Research |
2010-05-31 |
| NCT01028027 |
Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis |
https://ClinicalTrials.gov/show/NCT01028027 |
Completed |
Bausch & Lomb Incorporated |
2010-02-28 |
| NCT01013259 |
Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis |
https://ClinicalTrials.gov/show/NCT01013259 |
Completed |
Charite University, Berlin, Germany |
2009-09-30 |
| NCT01001091 |
AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation |
https://ClinicalTrials.gov/show/NCT01001091 |
Completed |
Alcon Research |
2010-04-30 |
| NCT00987272 |
Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects |
https://ClinicalTrials.gov/show/NCT00987272 |
Completed |
Alcon Research |
2009-11-30 |
| NCT00978029 |
Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081) |
https://ClinicalTrials.gov/show/NCT00978029 |
Completed |
ALK-Abelló A/S |
2010-02-28 |
| NCT00973453 |
Study With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis Patients |
https://ClinicalTrials.gov/show/NCT00973453 |
Completed |
HAL Allergy |
2010-08-31 |
| NCT00972777 |
Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00972777 |
Completed |
Bausch & Lomb Incorporated |
2010-10-31 |
| NCT00921895 |
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00921895 |
Completed |
Rapid Pathogen Screening |
2011-06-30 |
| NCT00917488 |
Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP). |
https://ClinicalTrials.gov/show/NCT00917488 |
Completed |
Laboratorios Leti, S.L. |
2010-05-31 |
| NCT00891436 |
Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms |
https://ClinicalTrials.gov/show/NCT00891436 |
Completed |
Rush University Medical Center |
2009-07-31 |
| NCT00889330 |
Safety and Efficacy Study of a Eye Drop for Eye Allergy |
https://ClinicalTrials.gov/show/NCT00889330 |
Completed |
Vistakon Pharmaceuticals |
2009-05-31 |
| NCT00889252 |
Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers |
https://ClinicalTrials.gov/show/NCT00889252 |
Completed |
Vistakon Pharmaceuticals |
2009-07-31 |
| NCT00884585 |
Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis |
https://ClinicalTrials.gov/show/NCT00884585 |
Completed |
Allergan |
2010-10-31 |
| NCT00882687 |
Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00882687 |
Completed |
Shire |
2009-05-31 |
| NCT00857779 |
Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients |
https://ClinicalTrials.gov/show/NCT00857779 |
Completed |
ALK-Abelló A/S |
2009-08-31 |
| NCT03878628 |
Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03878628 |
Recruiting |
Rigshospitalet, Denmark |
2020-04-30 |
| NCT00836485 |
Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00836485 |
Completed |
Senju USA, Inc. |
2009-03-31 |
| NCT00833495 |
Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation |
https://ClinicalTrials.gov/show/NCT00833495 |
Completed |
Fovea Pharmaceuticals SA |
2009-03-31 |
| NCT00833066 |
Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis |
https://ClinicalTrials.gov/show/NCT00833066 |
Completed |
BioTech Tools S.A. |
2009-10-31 |
| NCT00824447 |
Long-term Efficacy and Safety Study With Oralgen Grass Pollen |
https://ClinicalTrials.gov/show/NCT00824447 |
Completed |
Artu Biologicals |
2008-08-31 |
| NCT01634958 |
Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma |
https://ClinicalTrials.gov/show/NCT01634958 |
Completed |
Leti Pharma GmbH |
2013-04-30 |
| NCT02578914 |
A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT02578914 |
Completed |
Aldeyra Therapeutics, Inc. |
2015-12-31 |
| NCT00783198 |
Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00783198 |
Completed |
ALK-Abelló A/S |
2011-05-31 |
| NCT00775658 |
Olopatadine Eye Drops and Allergy Skin Testing |
https://ClinicalTrials.gov/show/NCT00775658 |
Completed |
Vanderbilt University Medical Center |
2008-06-30 |
| NCT00770315 |
Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234) |
https://ClinicalTrials.gov/show/NCT00770315 |
Completed |
ALK-Abelló A/S |
2011-05-31 |
| NCT00770133 |
Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis. |
https://ClinicalTrials.gov/show/NCT00770133 |
Completed |
Bausch & Lomb Incorporated |
2010-04-30 |
| NCT00769886 |
Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis. |
https://ClinicalTrials.gov/show/NCT00769886 |
Completed |
Bausch & Lomb Incorporated |
2008-12-31 |
| NCT00759148 |
Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00759148 |
Completed |
Alcon Research |
2010-03-31 |
| NCT00732446 |
Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00732446 |
Completed |
Federal University of São Paulo |
2008-12-31 |
| NCT00718744 |
Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units |
https://ClinicalTrials.gov/show/NCT00718744 |
Completed |
Laboratorios Leti, S.L. |
2008-11-30 |
| NCT00705159 |
Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis |
https://ClinicalTrials.gov/show/NCT00705159 |
Completed |
Bausch & Lomb Incorporated |
2010-03-31 |
| NCT00689078 |
Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model |
https://ClinicalTrials.gov/show/NCT00689078 |
Completed |
ORA, Inc. |
2008-06-30 |
| NCT00671268 |
Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma |
https://ClinicalTrials.gov/show/NCT00671268 |
Completed |
Allergopharma GmbH & Co. KG |
2012-03-31 |
| NCT00655109 |
A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00655109 |
Completed |
Greiner, Jack V., OD DO PhD |
2008-03-31 |
| NCT00652223 |
Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy |
https://ClinicalTrials.gov/show/NCT00652223 |
Completed |
Cytos Biotechnology AG |
NA |
| NCT00623701 |
Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation |
https://ClinicalTrials.gov/show/NCT00623701 |
Completed |
Allergopharma GmbH & Co. KG |
2011-10-31 |
| NCT00622908 |
Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00622908 |
Completed |
Bausch & Lomb Incorporated |
2005-06-30 |
| NCT00609128 |
Effect of Olopatadine on Allergic Tear Mediators |
https://ClinicalTrials.gov/show/NCT00609128 |
Completed |
University of Wisconsin, Madison |
2009-11-30 |
| NCT00800332 |
Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy |
https://ClinicalTrials.gov/show/NCT00800332 |
Completed |
Cytos Biotechnology AG |
2010-04-30 |
| NCT00586664 |
Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00586664 |
Completed |
Bausch & Lomb Incorporated |
2008-06-30 |
| NCT00586625 |
Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers |
https://ClinicalTrials.gov/show/NCT00586625 |
Completed |
Bausch & Lomb Incorporated |
2008-05-31 |
| NCT00581542 |
Moxifloxacin vs. Polytrim for Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00581542 |
Completed |
University of Rochester |
2009-03-31 |
| NCT00578955 |
Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis |
https://ClinicalTrials.gov/show/NCT00578955 |
Completed |
InSite Vision |
2008-10-31 |
| NCT00574704 |
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis |
https://ClinicalTrials.gov/show/NCT00574704 |
Completed |
Cytos Biotechnology AG |
2008-03-31 |
| NCT00574379 |
Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR |
https://ClinicalTrials.gov/show/NCT00574379 |
Completed |
Faes Farma, S.A. |
2008-03-31 |
| NCT00574223 |
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis |
https://ClinicalTrials.gov/show/NCT00574223 |
Completed |
Cytos Biotechnology AG |
2009-03-31 |
| NCT00569777 |
Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers |
https://ClinicalTrials.gov/show/NCT00569777 |
Completed |
Vistakon Pharmaceuticals |
2008-02-29 |
| NCT00567918 |
Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis |
https://ClinicalTrials.gov/show/NCT00567918 |
Completed |
Astellas Pharma Inc |
2008-01-31 |
| NCT00567762 |
Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis |
https://ClinicalTrials.gov/show/NCT00567762 |
Completed |
Astellas Pharma Inc |
NA |
| NCT00567346 |
Efficacy and Safety of Grass Pollen Sublingual Immunotherapy |
https://ClinicalTrials.gov/show/NCT00567346 |
Completed |
Artu Biologicals |
2007-10-31 |
| NCT00565123 |
Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00565123 |
Completed |
Laser Microsurgery Centre, Poland |
NA |
| NCT00562159 |
Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00562159 |
Completed |
ALK-Abelló A/S |
2009-09-30 |
| NCT00559546 |
Montelukast as a Controller of Atopic Syndrome |
https://ClinicalTrials.gov/show/NCT00559546 |
Completed |
University of Helsinki |
NA |
| NCT00550875 |
Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis |
https://ClinicalTrials.gov/show/NCT00550875 |
Completed |
Laboratorios Leti, S.L. |
2009-12-31 |
| NCT00550550 |
Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00550550 |
Completed |
ALK-Abelló A/S |
2009-09-30 |
| NCT00540631 |
Multicenter Trial of Immunotherapy With House Dust Mite Allergoid |
https://ClinicalTrials.gov/show/NCT00540631 |
Completed |
Allergopharma GmbH & Co. KG |
2010-08-31 |
| NCT00537342 |
Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT) |
https://ClinicalTrials.gov/show/NCT00537342 |
Completed |
Laboratorios Leti, S.L. |
2009-09-30 |
| NCT00534794 |
Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00534794 |
Completed |
Merck Sharp & Dohme Corp. |
2008-01-31 |
| NCT00518089 |
A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00518089 |
Completed |
Allergan |
2009-01-31 |
| NCT00509873 |
A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00509873 |
Completed |
Allergan |
2008-06-30 |
| NCT00501527 |
Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense |
https://ClinicalTrials.gov/show/NCT00501527 |
Completed |
Laboratorios Leti, S.L. |
2009-10-31 |
| NCT00464438 |
A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00464438 |
Completed |
Allergan |
2008-09-30 |
| NCT00445874 |
Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00445874 |
Completed |
Vistakon Pharmaceuticals |
NA |
| NCT00432757 |
Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00432757 |
Completed |
Vistakon Pharmaceuticals |
NA |
| NCT00424398 |
Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00424398 |
Completed |
Bausch & Lomb Incorporated |
2007-07-31 |
| NCT00423007 |
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00423007 |
Completed |
Bausch & Lomb Incorporated |
2007-08-31 |
| NCT00422149 |
Twin SUBLIVAC® Grasses Clinical Efficacy Study |
https://ClinicalTrials.gov/show/NCT00422149 |
Completed |
HAL Allergy |
2007-10-31 |
| NCT00407589 |
Systemic Pharmacokinetics of BOL-303224-A |
https://ClinicalTrials.gov/show/NCT00407589 |
Completed |
Bausch & Lomb Incorporated |
2007-10-31 |
| NCT00389025 |
Mast-Cell Stabilizing Effects of Olopatadine |
https://ClinicalTrials.gov/show/NCT00389025 |
Completed |
Alcon Research |
2007-04-30 |
| NCT00367640 |
Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis |
https://ClinicalTrials.gov/show/NCT00367640 |
Completed |
Stallergenes Greer |
2005-09-30 |
| NCT00364091 |
Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00364091 |
Completed |
Vistakon Pharmaceuticals |
2006-10-31 |
| NCT00357773 |
Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00357773 |
Completed |
Laboratoires Thea |
NA |
| NCT00348348 |
A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00348348 |
Completed |
Bausch & Lomb Incorporated |
2007-07-31 |
| NCT00347932 |
A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis. |
https://ClinicalTrials.gov/show/NCT00347932 |
Completed |
Bausch & Lomb Incorporated |
2007-11-30 |
| NCT00332293 |
AL-15469A for the Treatment of Bacterial Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00332293 |
Completed |
Alcon Research |
2006-12-31 |
| NCT00331916 |
AL-15469A for the Treatment of Bacterial Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00331916 |
Completed |
Alcon Research |
2007-05-31 |
| NCT00331500 |
Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00331500 |
Completed |
Alcon Research |
2006-07-27 |
| NCT00328653 |
Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC) |
https://ClinicalTrials.gov/show/NCT00328653 |
Completed |
Santen SAS |
NA |
| NCT00312338 |
Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora |
https://ClinicalTrials.gov/show/NCT00312338 |
Completed |
Alcon Research |
2007-06-30 |
| NCT00311844 |
A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209) |
https://ClinicalTrials.gov/show/NCT00311844 |
Completed |
Merck Sharp & Dohme Corp. |
2005-05-28 |
| NCT00266734 |
Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears |
https://ClinicalTrials.gov/show/NCT00266734 |
Completed |
Rapid Pathogen Screening |
NA |
| NCT00244543 |
Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00244543 |
Completed |
Vistakon Pharmaceuticals |
2005-11-30 |
| NCT00241319 |
Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00241319 |
Completed |
Vistakon Pharmaceuticals |
2005-12-31 |
| NCT00223951 |
Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers |
https://ClinicalTrials.gov/show/NCT00223951 |
Completed |
Vistakon Pharmaceuticals |
2005-12-31 |
| NCT00133627 |
Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis |
https://ClinicalTrials.gov/show/NCT00133627 |
Completed |
Novartis |
2005-10-31 |
| NCT00798577 |
Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment |
https://ClinicalTrials.gov/show/NCT00798577 |
Completed |
Alcon Research |
2009-02-28 |
| NCT00105534 |
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003) |
https://ClinicalTrials.gov/show/NCT00105534 |
Completed |
Merck Sharp & Dohme Corp. |
2006-01-31 |
| NCT00105469 |
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004) |
https://ClinicalTrials.gov/show/NCT00105469 |
Completed |
Merck Sharp & Dohme Corp. |
2005-10-31 |
| NCT00818805 |
Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR) |
https://ClinicalTrials.gov/show/NCT00818805 |
Completed |
Alcon Research |
2008-07-31 |
| NCT00818181 |
Open Label Safety Study of a Birch Pollen Allergen Extract |
https://ClinicalTrials.gov/show/NCT00818181 |
Completed |
Allergopharma GmbH & Co. KG |
2009-02-28 |